Evidence map›Paper›PMID 41246144›Full record

ArticleEndoscopy international open2025

Biliary stents reshape the bile microbiome in the absence of cholangitis.

Atsuto Kayashima, Seihiro Fukuhara, Kentaro Miyamoto, Eisuke Iwasaki, Motohiko Kato, Tomohisa Sujino

Erratum issuedAbstract read
In one paragraph

Article in Endoscopy international open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Microbial dysbiosis in cholangiocarcinoma.Frontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Atsuto KayashimaDepartment of Gastroenterology and Hepatology, National Hospital Organisation Tokyo Medical Center, Meguro, Japan.ORCID 0000-0002-3981-2984
Seihiro FukuharaDepartment of Gastroenterology and Hepatology, National Hospital Organisation Tokyo Medical Center, Meguro, Japan.
Kentaro MiyamotoResearch Department, R&D Division, Miyarisan Pharmaceutical Co. Ltd., Saitama, Japan.
Eisuke IwasakiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan.
Motohiko KatoCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine Graduate School of Medicine, Shinjuku, Japan.ORCID 0000-0002-7579-1316
Tomohisa SujinoLaboratory of Sakaguchi, Department of Multidimensional Analysis of Gastrointestinal Biology, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: Biliary stents are widely used in endoscopic retrograde cholangiopancreatography (ERCP), yet their impact on the native bile microbiome under non-infectious conditions remains unclear. We aimed to characterize stent-associated alterations in the biliary microbiome using 16S rRNA gene sequencing. Patients and methods: We analyzed bile samples collected during ERCP from 35 patients without clinical or laboratory evidence of acute cholangitis. Patients were categorized into a control group (n = 25; naïve papillae) and an endoscopic biliary stenting (EBS) group (n = 10; previously stented). Microbial composition was assessed using high-throughput 16S rRNA sequencing after propensity score matching to balance background characteristics. Results: Beta diversity differed significantly between groups (PERMANOVA, Conclusions: Endoscopic biliary stenting is associated with distinct bile microbiome alterations, characterized by enrichment of

Indexed as

ERC topicsHygienePancreatobiliary (ERCP/PTCD)Quality and logistical aspects

Identifiers

PMID41246144
PMCPMC12616555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.